Deputy director of CFDA visited Anhui Miao De Tang Pharmaceutical Co. Ltd. for research and guidance.2019-09-03
On the morning of August 31, 2019, Wang Shucai, deputy director of the Medical Device Supervision Department of the State Food and Drug Administration, visited Anhui Miao De Tang Pharmaceutical Co. Ltd. for research and guidance.
Accompanied by the general manager, the leaders visited the office building and production workshop of MEDITAN Company. Subsequently, the general manager introduced the company's current development scale and business status that achieved rectification results in terms of company management and services, personnel quality, and information construction.
After listening to the introduction, the leaders expressed their congratulations on the achievements and progress of MEDITAN in the standardized management of GMP. At the same time, they hope that MEDITAN will continue to make persistent efforts to continue to adhere to the concept of innovation and development, and to create new and innovative solutions for the industry to make bigger contribution!